BEAT Stock Analysis: Buy, Sell, or Hold?
BEAT - Heartbeam, Inc. Common Stock
$0.50
-0.02 (-3.21%)
▼
5d:
-2.17%
30d:
-31.36%
90d:
-41.66%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
10d
Get Alerted When BEAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BEAT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: BEAT shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: BEAT is currently trading at $0.50, which is considered oversold relative to its 30-day fair value range of $0.53 to $0.68.
Technical Outlook: Technically, BEAT is in a strong downtrend. The price is currently testing key support at $0.49. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.38 (+574.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BEAT is in a strong downtrend. The price is currently testing key support at $0.49. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.38 (+574.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.53 -
$0.68
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 574.2% below Wall St target ($3.38)
Trading Range Analysis
30-Day Trading Range
$0.53 -
$0.68
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.49
Resistance Level
$0.62
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.68
Wall Street Target
$3.38
(+574.2%)
Share & Embed Analysis
Last updated: August 02, 2026 3:16 PM ET
Data refreshes hourly during market hours. Next update: 4:16 PM
Data refreshes hourly during market hours. Next update: 4:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BEAT showing a specific setup today?
Insider Activity (6 Months)
7
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Branislav Vajdic
BUY
31250 shares
2026-04-16
Marga Ortigas-Wedekind
BUY
25000 shares
2026-04-16
Mark E Strome
BUY
750000 shares
2026-04-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 59 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 53 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 50 HOLD |
